Acknowledgements.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 95, doi. 10.1177/1758834012470793
- Publication type:
- Article
Works matching IS 17588340 AND DT 2013 AND VI 5 AND IP 1
Results: 10
1
2
Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 93, doi. 10.1177/1758834012469430
- By:
- Publication type:
- Article
3
Targeted therapies in medical oncology: successes, failures and next steps.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 5, doi. 10.1177/1758834012467829
- By:
- Publication type:
- Article
4
Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 91, doi. 10.1177/1758834012464806
- By:
- Publication type:
- Article
5
New treatment approaches in melanoma: current research and clinical prospects.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 73, doi. 10.1177/1758834012463260
- By:
- Publication type:
- Article
6
Immunotherapy updates in pancreatic cancer: are we there yet?
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 81, doi. 10.1177/1758834012462463
- By:
- Publication type:
- Article
7
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 51, doi. 10.1177/1758834012462462
- By:
- Publication type:
- Article
8
New agents on the horizon in hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 41, doi. 10.1177/1758834012458480
- By:
- Publication type:
- Article
9
The changing landscape in the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 25, doi. 10.1177/1758834012458137
- By:
- Publication type:
- Article
10
Combining Notch inhibition with current therapies for breast cancer treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 17, doi. 10.1177/1758834012457437
- By:
- Publication type:
- Article